Tivic Health's Leadership at BioFuture Conference 2024
In an exciting announcement, Tivic Health Systems, Inc. (NASDAQ: TIVC), a trailblazer in health technology and bioelectronic medicine, is set to showcase its advancements at the upcoming BioFuture 2024 Conference in New York. Their CEO, Jennifer Ernst, will take the stage to present groundbreaking data related to vagus nerve stimulation treatment approaches.
Focusing on Bioelectronic Medicine
Key Highlights of the Presentation
Jennfer Ernst's presentation, scheduled for October 29th at 2:30 p.m. EDT, will delve into pioneering developments in the field of bioelectronic medicine. As interest in these innovative treatments continues to escalate, Ernst stated, "This year, BioFuture 2024 highlights bioelectronic solutions as more industry leaders come together to reassess health approaches. Our collaboration with esteemed clinical partners like Dr. Kevin Tracey strengthens our mission to expand therapeutic options through our vagus nerve stimulation platform."
Understanding Vagus Nerve Stimulation
Vagus nerve stimulation is gaining attention for its revolutionary potential in treating various conditions such as rheumatoid arthritis, Crohn's disease, cancer, diabetes, and mental health disorders. BioFuture 2024 aims to elevate conversations around these powerful treatment possibilities, enhancing investor and practitioner interest.
One-on-One Meetings for Investors
Participants in the BioFuture Showcase Partnering Platform can look forward to scheduling one-on-one meetings with Jennifer Ernst. Interested parties are encouraged to access this opportunity for deeper engagement in Tivic Health's ongoing developments.
Event Benefits and Virtual Access
Following the in-person presentations, there will be a virtual component from November 5-7 to provide global audiences with accessible recorded sessions and opportunities for additional meetings. This continued engagement will facilitate important discussions surrounding innovative treatment development.
About Tivic Health Systems, Inc.
Tivic Health is at the forefront of health technology with a focus on advancing bioelectronic medicine. Their patented technology platform effectively utilizes targeted stimulation of the trigeminal, sympathetic, and vagus nerve structures. Through its non-invasive methods, Tivic Health offers drug-free therapeutic solutions with an impressive safety profile and versatility in treating chronic inflammatory conditions.
The flagship product, ClearUP, is an FDA-approved handheld device designed to combat sinus issues, available through various online retailers and commercial distributors. With strong efficacy, it represents a significant leap in patient-centric health solutions.
Frequently Asked Questions
What is Tivic Health known for?
Tivic Health specializes in bioelectronic medicine, offering innovative, non-invasive devices to treat chronic health conditions.
Who is Jennifer Ernst?
Jennifer Ernst is the CEO of Tivic Health, leading the company in advancing bioelectronic therapy solutions.
What will the BioFuture Conference discuss?
The conference will focus on the impact of bioelectronic medicine, including advancements in vagus nerve stimulation treatments.
How can investors connect with Tivic Health?
Investors can schedule one-on-one meetings with CEO Jennifer Ernst through the BioFuture Showcase Partnering Platform.
What is the ClearUP device?
ClearUP is Tivic Health's FDA-approved bioelectronic sinus device, providing drug-free relief for sinus issues.
